1.Cyber-knife—A New Stereotaxic Radiosurgery Instrument for Intracranial Neoplasms and Extracranial Tumors
Bing LI ; Qihui FENG ; Junshu SHEN
Chinese Medical Equipment Journal 1989;0(01):-
Cyber -knife a new stereotaxic radiosurgery instrument, which structure and technical characteristics are introduced. By application of real-time image aiming and synchronous dynamic tracking techniques, abandoning vicious location frame to solve the questions of traditional directional radiosurgery technique only use pate tumour. Cyber-knife is an innovative stereotaxic radiosurgery instrument, extends the indications of stereotaxic radiosurgery from intracranial neoplasms to extracranial tumors and has a widest development prospect in medical treatment.
2.Study on the application of personalization customized oral positioning stent in head and neck cancer patients with intensity modulated radiation therapy
Feng CHEN ; Lei ZHU ; Xixu ZHU ; Meng ZHANG ; Shengqi ZANG ; Rui MU ; Junshu SHEN ; Han ZHOU ; Xiaolei SHI ; Lei JIN
Journal of Medical Postgraduates 2017;30(5):491-494
Objective Head and neck cancer radiotherapy patients often appear a series of oral complications including mucositis, xerostomia, pain, dysphagia.The purpose of this study was to investigate whether personalization customized positioning oral stent was able to push normal tissue off the high dose target area and maintain accurate repeatable stable positions, thus protecting the normal tissue during radiotherapy of the nasopharyngeal carcinoma patients.Methods 15 newly diagnosed nasopharyngeal carcinoma patients were collected from March to August 2016 in Department of Radiation Oncology, Nanjing General Hospital of Nanjing Military Region and randomly divided into trial group and control group.Two groups of patients were treated with intensity modulated radiation therapy (IMRT).Trial group patients wear personalization customized oral positioning stents during radiotherapy while the control group did not wear.After radiotherapy, we compared the exposure doses of clinical target area(CTV) and normal oral tissue in two groups.ResultsThe left parotid gland radiotherapy doses of the trail group and the control group were 2223.557±294.549 cGy and 2900.563±374.660 cGy, the difference was statistically significant(t=3.847, P=0.002);the right parotid gland radiotherapy doses of the trail group and control group were 2284.957±256.673 cGy and 2994.670±339.264 cGy, the difference was statistically significant(t=4.512, P=0.001).The mean exposure doses of CTV in two groups were no statistically significant difference (6142.829±135.986 cGy vs 173.306±6221.825 cGy, t=0.971, P=0.349.Conclusion During the intensity modulated radiation therapy, patients with personalization customized oral positioning stents can keep the mandible in a precise repeatable stable position.And it can reduce the exposure dose of bilateral parotid without affect the radiotherapy effect of the clinical target area.
3.miR-452-5p promotes the proliferation, invasion and EMT of esophageal cancer KYSE-150 cells via targeting SOX7
YIN Qing ; HAN Junshu ; DONG Zhiming ; GUO Wei ; SHEN Supeng ; LIANG Jia ; LU Juntao ; GUO Yanli
Chinese Journal of Cancer Biotherapy 2022;29(4):294-300
[摘 要] 目的:检测miR-452-5p在食管鳞状细胞癌(ESCC)中的表达,并探讨其异常表达对食管癌KYSE-150细胞增殖、侵袭能力和EMT进程的影响及其分子机制。方法:收集2012年3月至2015年12月在河北医科大学第四医院就诊的86名ESCC患者的癌组织样本和对应的癌旁组织,用qPCR法检测miR-452-5p及其他相关基因在ESCC组织和细胞中的表达;向KYSE-150细胞中分别转染miR-452-5p mimic或pcDNA3.1-SOX7构建过表达的细胞株。分析miR-452-5p表达与ESCC病理特征和患者5年OS的关系。用MTS、Tanswell法检测miR-452-5p过表达对食管癌KYSE-150细胞增殖、侵袭能力和EMT进程的影响;用双荧光素酶报告基因实验及TOP/FOP报告基因系统检测miR-452-5p与SRY盒转录因子(SOX7)3'UTR区的结合作用及对Wnt/β-catenin通路活化水平的影响。结果:miR-452-5p在ESCC组织中呈明显高表达(P<0.01),并与ESCC患者的淋巴结转移、TNM分期及5年OS密切相关(均P<0.01)。miR-452-5p过表达明显促进食管癌KYSE-150细胞的增殖、侵袭能力及EMT进程(P<0.05或P<0.01)。SOX7是miR-452-5p的直接靶基因,miR-452-5p通过对SOX7的负向调控影响了Wnt通路活化水平(P<0.05或P<0.01),同时,miR-452-5p表达也受Wnt通路活化水平的影响(P<0.05或P<0.01),其可能为Wnt通路下游靶基因。结论:miR-452-5p通过miR-452-5p/SOX7/Wnt/miR-452-5p正反馈环路提高Wnt/β-catenin通路活化水平,进而促进ESCC KYSE-150细胞的增殖、侵袭能力及EMT进程,miR-452-5p有望成为ESCC患者靶向治疗的潜在靶点及预后评估的新型分子标志物。
4.LINC01140 regulates the proliferation and invasion of esophageal squamous cell carcinoma Eca109 cells via miR-452-5p/Wnt/β-catenin axis
GUO Yanli ; YIN Qing ; HAN Junshu ; GUO Wei, ; SHEN Supeng ; LIANG Jia ; DONG Zhiming
Chinese Journal of Cancer Biotherapy 2021;28(9):900-907
[摘 要] 目的: 探讨长链非编码RNA(lncRNA)LINC01140在食管鳞状细胞癌(esophageal squamous cell carcinoma,ESCC)组织及细胞中的表达及其对Eca109细胞增殖与侵袭的影响及其分子机制。方法:选取2012年3月至2015年5月河北医科大学第四医院收治的133例ESCC患者的临床资料和GEPIA数据库中收集的182例ESCC组织及286例食管正常黏膜组织的LINC01140表达数据,以及ESCC细胞系Kyse150、Eca109和TE13。用qPCR法检测癌组织和细胞中LINC01140的表达水平,分析其表达水平与患者临床病理特征及预后的关系。分别将pcDNA3.1-LINC01140、阴性对照(pcDNA3.1-NC)或miR-452-5p mimic及阴性对照(miR-NC)转染到Eca109细胞,MTS、Transwell实验分别检测细胞的增殖与侵袭能力。用双荧光报告基因实验及TOP/FOP报告基因系统检测LINC01140与miR-452-5p的靶向结合作用及LINC01140对Wnt/β-catenin通路活化水平的影响。结果:LINC01140在ESCC组织和细胞中表达均显著下调(均P<0.01),LINC01140低表达与ESCC患者年龄、淋巴结转移、TNM分期及OS密切相关(均P<0.05)。LINC01140过表达明显抑制Eca109细胞的增殖及侵袭能力(均P<0.01)。机制研究表明,LINC01140可能通过竞争结合miR-452-5p影响Wnt/β-catenin信号通路的活化水平继而调控Eca109细胞的恶性生物学行为。结论:LINC01140通过靶向miR-452-5p/Wnt/β-catenin轴促进ESCC细胞的增殖与侵袭能力,其有望成为ESCC患者靶向治疗的潜在靶点及预后评估的标志物。